SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,235 | -25.4% | 4,967 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $23,097 | +47.0% | 4,967 | +46.1% | 0.00% | 0.0% |
| Q1 2023 | $15,708 | -38.7% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,636 | +42.4% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $18,000 | +5.9% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | -39.3% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $28,000 | -45.1% | 3,400 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $51,000 | -20.3% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $64,000 | +1.6% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $63,000 | +5.0% | 3,400 | +28.6% | 0.00% | 0.0% |
| Q1 2021 | $60,000 | +25.0% | 2,644 | +19.0% | 0.00% | 0.0% |
| Q4 2020 | $48,000 | +118.2% | 2,222 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $22,000 | +83.3% | 2,222 | +49.9% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | +140.0% | 1,482 | +182.3% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 525 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 525 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -16.7% | 525 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 525 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +20.0% | 525 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | – | 525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |